|
業務類別
|
-- |
|
業務概覽
|
CStone Pharmaceuticals is engaged in developing and commercializing of immuno-oncology and molecularly targeted drugs to address unmet medical needs in cancer treatment. |
| 公司地址
| 218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Suzhou, CHN, 215123 |
| 電話號碼
| +86 51287186550 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.cstonepharma.com |
| 員工數量
| 230 |
| Dr. Jianxin Yang, M.D.,PhD |
Director, Chief Executive Officer and President, Research and Development |
-- |
28/04/2025 |
|
|
| Dr. Paul Herbert Chew, PhD |
Independent Director |
28/04/2025 |
| Ms. Yip Betty Ho |
Independent Director |
28/04/2025 |
| Dr. Jianxin Yang, M.D.,PhD |
Director, Chief Executive Officer and President, Research and Development |
28/04/2025 |
| Mr. Kenneth Walton Hitchner, III |
Director |
28/04/2025 |
| Mr. Xianghong Lin |
Director |
28/04/2025 |
| Mr. Ting Yuk Anthony Wu |
Independent Director |
28/04/2025 |
| Dr. Wei Li, PhD |
Non-Executive Chairman of the Board |
28/04/2025 |
| Mr. Hongbin Sun |
Independent Director |
28/04/2025 |
| Mr. Edward Hu |
Director |
28/04/2025 |
|
|
|
|
